Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Ross

Showing results (31-40 of 244) with videos related to

Pageof 25
Sort By:
Journal of Neurochemistry|May 18, 2016
DISC1, astrocytes and neuronal maturation: a possible mechanistic link with implications for mental disordersMeng Xia, Shanshan Zhu, Alexey Shevelkin, et al.
The Journal of Biological Chemistry|February 12, 2011
Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtinTamara Ratovitski, Ekaterine Chighladze, Elaine Waldron, et al.
Cell Cycle (Georgetown, Tex.)|May 1, 2015
PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD)Tamara Ratovitski, Nicolas Arbez, Jacqueline C Stewart, et al.
Journal of Neuropathology and Experimental Neurology|January 17, 2003
Transglutaminase cross-links in intranuclear inclusions in Huntington diseaseGina M Zainelli, Christopher A Ross, Juan C Troncoso, et al.
Pharmacological Research|January 18, 2011
Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for ParkinsonismZhaohui Liu, Yi Yu, Xueping Li, et al.
Nature Reviews. Neurology|August 16, 2020
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunitiesSarah J Tabrizi, Michael D Flower, Christopher A Ross, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2005
A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuseNaoya Sawamura, Takako Sawamura-Yamamoto, Yuji Ozeki, et al.
Neurobiology of Disease|May 24, 2005
Compounds blocking mutant huntingtin toxicity identified using a Huntington's disease neuronal cell modelWenfei Wang, Wenzhen Duan, Shuichi Igarashi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 30, 2002
Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein lengthLuis Pereira de Almeida, Christopher A Ross, Diana Zala, et al.
Human Molecular Genetics|November 11, 2008
Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brainJonathan D Wood, Franziska Bonath, Shashvita Kumar, et al.
Pageof 25

Showing results (31-40 of 244) with videos related to

Sort By:
Pageof 25
Journal of Neurochemistry|May 18, 2016
DISC1, astrocytes and neuronal maturation: a possible mechanistic link with implications for mental disordersMeng Xia, Shanshan Zhu, Alexey Shevelkin, et al.
The Journal of Biological Chemistry|February 12, 2011
Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtinTamara Ratovitski, Ekaterine Chighladze, Elaine Waldron, et al.
Cell Cycle (Georgetown, Tex.)|May 1, 2015
PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD)Tamara Ratovitski, Nicolas Arbez, Jacqueline C Stewart, et al.
Journal of Neuropathology and Experimental Neurology|January 17, 2003
Transglutaminase cross-links in intranuclear inclusions in Huntington diseaseGina M Zainelli, Christopher A Ross, Juan C Troncoso, et al.
Pharmacological Research|January 18, 2011
Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for ParkinsonismZhaohui Liu, Yi Yu, Xueping Li, et al.
Nature Reviews. Neurology|August 16, 2020
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunitiesSarah J Tabrizi, Michael D Flower, Christopher A Ross, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2005
A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuseNaoya Sawamura, Takako Sawamura-Yamamoto, Yuji Ozeki, et al.
Neurobiology of Disease|May 24, 2005
Compounds blocking mutant huntingtin toxicity identified using a Huntington's disease neuronal cell modelWenfei Wang, Wenzhen Duan, Shuichi Igarashi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 30, 2002
Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein lengthLuis Pereira de Almeida, Christopher A Ross, Diana Zala, et al.
Human Molecular Genetics|November 11, 2008
Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brainJonathan D Wood, Franziska Bonath, Shashvita Kumar, et al.
Pageof 25